Tuesday - April 14, 2026

Category Archives: Pharmaceuticals & Biotech

Innovative Portable Oxygen Therapy Device: Inogen One G4 Handheld Oxygen Concentrator Enhances Mobility and Quality of Life for Oxygen-Dependent Users Worldwide

The Inogen One G4 Handheld Oxygen Concentrator, available at O2Xpress, represents a major advancement in portable oxygen therapy. This lightweight, compact device offers unmatched mobility, convenience, and performance for individuals who require supplemental oxygen. Designed for active lifestyles—whether at home, … Continue reading →

Neurofibromatosis Type 2 Treatment Pipeline Shows Strong Momentum as 5+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Neurofibromatosis Type 2 Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Neurofibromatosis Type 2 pipeline landscape. It covers the Neurofibromatosis Type 2 Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

HPV+ Recurrent/Metastatic Head and Neck Cancer Clinical Trial Pipeline Expands as 5+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “HPV+ Recurrent/Metastatic Head and Neck Cancer Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the HPV+ Recurrent/Metastatic Head and Neck Cancer pipeline landscape. It covers the HPV+ Recurrent/Metastatic Head and Neck Cancer … Continue reading →

Catheter-Related Bloodstream Infections Clinical Trial Pipeline Shows Potential with Active Contributions from 5+ Key Companies | DelveInsight

DelveInsight’s “Catheter-Related Bloodstream Infections Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Catheter-Related Bloodstream Infections pipeline landscape. It covers the Catheter-Related Bloodstream Infections Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Tetanus Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Tetanus Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Tetanus pipeline landscape. It covers the Tetanus Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Tetanus Pipeline … Continue reading →

Staphylococcal Infections Clinical Trial Pipeline Gains Momentum: 22+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Staphylococcal Infections Pipeline Insight 2026” report provides comprehensive insights about 22+ companies and 23+ pipeline drugs in the Staphylococcal Infections pipeline landscape. It covers the Staphylococcal Infections Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology

As the global race to treat metabolic dysfunction–associated steatotic liver disease (MASLD) and expand GLP-1 therapies accelerates, a critical challenge is emerging across the pharmaceutical industry: clinical trial infrastructure is struggling to scale—especially liver imaging. With trial sizes increasing, durations … Continue reading →